Transcatheter mitral valve edge-to-edge repair (M-TEER) can stabilize high-risk patients with marantic endocarditis, facilitating timely cancer treatment.
Does transcatheter mitral repair (M-TEER) stabilize patients with marantic endocarditis to enable cancer therapy?
M-TEER can serve as an effective bridge to cancer therapy in high-risk patients with marantic endocarditis.
Absolute Event Rate: 0% vs 0%
NBTE may be the first sign of malignancy and should be considered in patients with embolism and sterile valve lesions. M-TEER can stabilize high-risk patients and enable timely, potentially curative cancer treatment.
Hauptmann et al. (Thu,) reported a other. Transcatheter mitral valve edge-to-edge repair (M-TEER) can stabilize high-risk patients with marantic endocarditis, facilitating timely cancer treatment.